LORATADINE AND PSEUDOEPHEDRINE SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Loratadine And Pseudoephedrine Sulfate, and what generic alternatives are available?
Loratadine And Pseudoephedrine Sulfate is a drug marketed by Bionpharma, Heritage Pharma, P And L, Perrigo Pharma Intl, and Sun Pharm Inds Ltd. and is included in six NDAs.
The generic ingredient in LORATADINE AND PSEUDOEPHEDRINE SULFATE is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Loratadine And Pseudoephedrine Sulfate
A generic version of LORATADINE AND PSEUDOEPHEDRINE SULFATE was approved as loratadine; pseudoephedrine sulfate by PERRIGO PHARMA INTL on January 30th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LORATADINE AND PSEUDOEPHEDRINE SULFATE?
- What are the global sales for LORATADINE AND PSEUDOEPHEDRINE SULFATE?
- What is Average Wholesale Price for LORATADINE AND PSEUDOEPHEDRINE SULFATE?
Summary for LORATADINE AND PSEUDOEPHEDRINE SULFATE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 32 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 6 |
| Patent Applications: | 2 |
| DailyMed Link: | LORATADINE AND PSEUDOEPHEDRINE SULFATE at DailyMed |
Recent Clinical Trials for LORATADINE AND PSEUDOEPHEDRINE SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bayer | Phase 1 |
| Bayer | Phase 4 |
| Azidus Brasil | Phase 3 |
See all LORATADINE AND PSEUDOEPHEDRINE SULFATE clinical trials
Pharmacology for LORATADINE AND PSEUDOEPHEDRINE SULFATE
| Drug Class | alpha-Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha-Agonists |
US Patents and Regulatory Information for LORATADINE AND PSEUDOEPHEDRINE SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma | LORATADINE AND PSEUDOEPHEDRINE SULFATE | loratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 218017-001 | May 14, 2024 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Perrigo Pharma Intl | LORATADINE AND PSEUDOEPHEDRINE SULFATE | loratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 076050-001 | Jan 30, 2003 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Heritage Pharma | LORATADINE AND PSEUDOEPHEDRINE SULFATE | loratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 076208-001 | Jan 28, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
